{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:24:33Z","timestamp":1761578673359,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.carrev.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:27:16Z","timestamp":1637720836000},"page":"144-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access \u2013 Results From the German Austrian ABSORB Registry (GABI-R)"],"prefix":"10.1016","volume":"40","author":[{"given":"Bastian","family":"Wein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Zaczkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger M.","family":"Nef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"W\u00f6hrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Torzewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"The M Word: Is Routine Transfemoral PCI Defensible in 2018?","author":"Neale","key":"10.1016\/j.carrev.2021.11.022_bb0005"},{"key":"10.1016\/j.carrev.2021.11.022_bb0010","article-title":"Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease","volume":"4","author":"Kolkailah","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.carrev.2021.11.022_bb0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire Spectrum of patients with coronary artery disease: a meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.11.022_bb0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcin.2012.10.016","article-title":"Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial","volume":"6","author":"Jolly","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.carrev.2021.11.022_bb0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"ESC\/EACTS Guidelines on myocardial revascularization","volume":"2019","author":"Neumann","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.11.022_bb0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0002-8703(99)70143-2","article-title":"Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison","volume":"138","author":"Cooper","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2021.11.022_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18116151","article-title":"Comparison of Access Site-Related Complications and Quality of Life in Patients after Invasive Cardiology Procedures According to the Use of Radial, Femoral, or Brachial Approach","volume":"18","author":"Roczniak","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.carrev.2021.11.022_bb0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ahj.2015.04.024","article-title":"Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: results of the study of access site for enhancement of percutaneous coronary intervention for women quality-of-life substudy","volume":"170","author":"Hess","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2021.11.022_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000397","article-title":"Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry","volume":"3","author":"Dobies","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.carrev.2021.11.022_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12471-016-0887-6","article-title":"Effects of radial versus femoral artery access in patients with acute myocardial infarction: a large Centre prospective registry","volume":"25","author":"Kilic","year":"2017","journal-title":"Neth Hear J"},{"issue":"22","key":"10.1016\/j.carrev.2021.11.022_bb0055","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.jcin.2019.05.051","article-title":"Primary and secondary vascular access site complications associated with percutaneous coronary intervention: insights from the BMC2 registry","volume":"12","author":"Kopin","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.11.022_bb0060","series-title":"American College of Cardiology annual scientific session (ACC 2019)","article-title":"SAfety and efficacy of femoral access vs radial access in STEMI - SAFARI-STEMI","author":"Le May","year":"2019"},{"key":"10.1016\/j.carrev.2021.11.022_bb0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(18)31714-8","article-title":"Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial","volume":"392","author":"Valgimigli","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.11.022_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.carrev.2015.09.002","article-title":"Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: rationale and design of the german-austrian ABSORB RegIstRy (GABI-R)","volume":"17","author":"Nef","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2021.11.022_bb0075","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.11.022_bb0080","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.carrev.2021.11.022_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10198-004-0264-z","article-title":"Validating the EQ-5D with time trade off for the german population","volume":"6","author":"Greiner","year":"2005","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.carrev.2021.11.022_bb0090","series-title":"Qualitaetsreport 2019","first-page":"242","article-title":"Qualit\u00e4tsreport 2019","author":"Wolfschuetz","year":"2019"},{"key":"10.1016\/j.carrev.2021.11.022_bb0095","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12181-010-0297-8","article-title":"25. Bericht \u00fcber die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland","volume":"4","author":"van Buuren","year":"2010","journal-title":"Der Kardiologe"},{"key":"10.1016\/j.carrev.2021.11.022_bb0100","first-page":"16","article-title":"Cardiac catheterization coronary angiography (CA) and percutaneous coronary interventions (PCI) in Austria during the year 2017 (Registry data including audit 2018)","volume":"26","author":"Muehlberger","year":"2019","journal-title":"Aust J Cardiol"},{"key":"10.1016\/j.carrev.2021.11.022_bb0105","article-title":"Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX","volume":"10","author":"Ando","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.11.022_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.carrev.2016.05.008","article-title":"Radiation exposure and contrast agent use related to radial versus femoral arterial access during percutaneous coronary intervention (PCI)-results of the FERARI study","volume":"17","author":"Becher","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2021.11.022_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002049","article-title":"Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial","volume":"8","author":"Hamon","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.11.022_bb0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0300-8932(09)71028-0","article-title":"The left radial approach in daily practice. A randomized study comparing femoral and right and left radial approaches","volume":"62","author":"Santas","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.carrev.2021.11.022_bb0125","first-page":"421","article-title":"Outpatient coronary angioplasty: feasible and safe","volume":"64","author":"Slagboom","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.11.022_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2014.05.030","article-title":"Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention\u2013radial versus femoral access (from the OCEAN RACE Trial)","volume":"114","author":"Koltowski","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.11.022_bb0135","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","article-title":"Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice","volume":"53","author":"Doyle","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.11.022_bb0140","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921007491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921007491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:24:28Z","timestamp":1761560668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921007491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"alternative-id":["S1553838921007491"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.11.022","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access \u2013 Results From the German Austrian ABSORB Registry (GABI-R)","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}